Join us March 24-25 in Dallas and learn key financial and operational challenges that physician leaders face right now. Register now
This latest weekly roundup covers dissolving contacts for dispensing glaucoma medication, a helpful app and a failed squalamine trial. Read
The cost to restore sight to the blind will be $425,000 per eye. Pricing for the gene therapy drug was announced 2 weeks after its landmark approval. Read
The FDA has approved Luxturna, a one-time injection that can significantly increase functional vision in patients with inherited retinal dystrophies. Read
Research to Prevent Blindness will award 6 grants to researchers that utilize the IRIS Registry. Apply now
Learn the ins and outs of business and career planning in this 5-part lecture series for residents and fellows. Get started
Select your calendar system below.
Note: You will have to be signed in to your calendar and may have to enable pop-ups to add events.
Editor-in-Chief, the ONE NetworkRahul Khurana, MD
Deputy Editor-in-Chief, the ONE NetworkChirag P. Shah, MD, MPH
Senior Editor, Comprehensive OphthalmologyDamien M. Luviano, MD, FACS
Committee MembersRebekah C. Allen, MDCarl Danzig, MDPriya V. Desai, MDMisha Faustina, MD, FACS Charles C. Wykoff, MD, PhD, FACSBarbara S. Yates, MD